Talaris relaunches in Boston with $100M for organ transplant drug replacement

The newly retooled company will use the money to develop a stem cell treatment that could permanently replace the immuno-supressing drugs people who have received transplants must take to stop their body from rejecting the organ.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news